Published in J Clin Oncol on September 01, 1998
Breathing new life into immunotherapy: review of melanoma, lung and kidney cancer. Nat Rev Clin Oncol (2013) 2.64
Cellular vaccine approaches. Cancer J (2010) 1.27
Effect of granulocyte/macrophage colony-stimulating factor on vaccination with an allogeneic whole-cell melanoma vaccine. Clin Cancer Res (2009) 1.17
Prolonged survival of patients receiving active immunotherapy with Canvaxin therapeutic polyvalent vaccine after complete resection of melanoma metastatic to regional lymph nodes. Ann Surg (2002) 1.11
Survivin expression by metastatic melanoma predicts poor disease outcome in patients receiving adjuvant polyvalent vaccine. Int J Cancer (2005) 1.03
Autologous cell vaccine as a post operative adjuvant treatment for high-risk melanoma patients (AJCC stages III and IV). The new American Joint Committee on Cancer. Br J Cancer (2002) 0.90
Metastatic melanomas express inhibitory low affinity fc gamma receptor and escape humoral immunity. Dermatol Res Pract (2010) 0.90
Cancer vaccines: on the threshold of success. Expert Opin Emerg Drugs (2008) 0.87
Tumor antigens for cancer immunotherapy: therapeutic potential of xenogeneic DNA vaccines. J Transl Med (2004) 0.86
Tumor-Associated Glycans and Immune Surveillance. Vaccines (Basel) (2013) 0.86
Attenuated Toxoplasma gondii therapy of disseminated pancreatic cancer generates long-lasting immunity to pancreatic cancer. Oncoimmunology (2015) 0.76
Prospects in the Application of Photodynamic Therapy in Oral Cancer and Premalignant Lesions. Cancers (Basel) (2016) 0.75
Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol (2001) 9.68
Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg (1994) 8.85
Prognostic factors in 1,521 melanoma patients with distant metastases. J Am Coll Surg (1995) 4.37
Impaired immunologic reactivity and recurrence following cancer surgery. Cancer (1970) 3.77
Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg (1995) 3.62
Demonstration of antibodies against human malignant melanoma by immunofluorescence. Surgery (1968) 3.56
IL-4 down-regulates IL-1 and TNF gene expression in human monocytes. J Immunol (1989) 2.86
Health innovation networks to help developing countries address neglected diseases. Science (2005) 2.72
Diagnostic testing for serious bacterial infections in infants aged 90 days or younger with bronchiolitis. Arch Pediatr Adolesc Med (1999) 2.40
Malignant melanoma. Effects of an early structured psychiatric intervention, coping, and affective state on recurrence and survival 6 years later. Arch Gen Psychiatry (1993) 2.38
Antibody responses in serum, colostrum, and milk of swine after infection or vaccination with transmissible gastroenteritis virus. Infect Immun (1972) 2.37
Improvements in optical methods for measuring rapid changes in membrane potential. J Membr Biol (1981) 2.34
Occult tumor cells in the lymph nodes of patients with pathological stage I malignant melanoma. An immunohistological study. Am J Surg Pathol (1988) 2.32
Risk of second malignancy after Hodgkin's disease in a collaborative British cohort: the relation to age at treatment. J Clin Oncol (2000) 2.29
Adrenal tumor complicating untreated 21-hydroxylase deficiency in a 5 1/2-year-old boy. Am J Dis Child (1993) 2.18
BCG immunotherapy of malignant melanoma: summary of a seven-year experience. Ann Surg (1974) 2.14
Efficacy of lymphatic mapping, sentinel lymphadenectomy, and selective complete lymph node dissection as a therapeutic procedure for early-stage melanoma. Ann Surg Oncol (1999) 2.08
31P NMR studies of intracellular free Mg2+ in intact frog skeletal muscle. J Biol Chem (1980) 2.01
NMR studies of intracellular metal ions in intact cells and tissues. Annu Rev Biophys Bioeng (1984) 1.97
Parathyroid carcinoma: a collective review. Ann Surg (1969) 1.94
Surgical resection for melanoma metastatic to the gastrointestinal tract. Arch Surg (1996) 1.91
Impact of T-cell costimulation modulation in patients with undifferentiated inflammatory arthritis or very early rheumatoid arthritis: a clinical and imaging study of abatacept (the ADJUST trial). Ann Rheum Dis (2009) 1.90
The nature of immune complexes in human cancer sera. J Immunol (1977) 1.88
A rational approach to the surgical management of melanoma. Ann Surg (1977) 1.88
Pulsed NMR study of the structure of cytochrome c. Cold Spring Harb Symp Quant Biol (1972) 1.85
Lymphocyte-mediated cellular immunity in histoplasmosis. Infect Immun (1971) 1.83
Comparative evaluation of fungal, tubercular, and pyogenic brain abscesses with conventional and diffusion MR imaging and proton MR spectroscopy. AJNR Am J Neuroradiol (2007) 1.78
Immunomonitoring followed by optimal dec therapy for successful management of clinical filariasis in an endemic area. Indian J Clin Biochem (1999) 1.76
MRI in Japanese encephalitis. Neuroradiology (1997) 1.75
Pre-induction LDH as a prognostic factor for outcome of high dose chemotherapy (HDCT) for germ cell tumours relapsing or refractory to conventional chemotherapy. Br J Cancer (2000) 1.74
Complications of BCG immunotherapy in patients with cancer. N Engl J Med (1973) 1.72
Tumor doubling time: a selection factor for pulmonary resection of metastatic melanoma. J Surg Oncol (1998) 1.71
Parkinsonism due to predominant involvement of substantia nigra in Japanese encephalitis. Neurology (1999) 1.71
Radiofrequency ablation: a minimally invasive technique with multiple applications. Cancer J Sci Am (1999) 1.70
Immunological factors in human sarcomas and melanomas: a rational basis for immunotherapy. Ann Surg (1970) 1.68
Detection of occult melanoma cells in blood with a multiple-marker polymerase chain reaction assay. J Clin Oncol (1995) 1.66
Can elective lymph node dissection decrease the frequency and mortality rate of late melanoma recurrences? Ann Surg Oncol (2000) 1.64
Long-term survival after complete resection of melanoma metastatic to the adrenal gland. Ann Surg Oncol (1999) 1.63
Genetic analysis of the human tumor necrosis factor alpha/cachectin promoter region in a macrophage cell line. J Exp Med (1989) 1.62
Cyanine dye labeling reagents for sulfhydryl groups. Cytometry (1989) 1.61
Does endogenous immune response determine the outcome of surgical therapy for metastatic melanoma? Ann Surg Oncol (2000) 1.59
Age specific incidence rate and pathological spectrum of oral cancer in Allahabad. Indian J Med Sci (2003) 1.59
Human osteosarcomas: immunologic evidence suggesting an associated infectious agent. Science (1968) 1.58
Detection of antibody and complement complexed in vivo on membranes of human cancer cells by mixed hemadsorption techniques. Cancer Res (1975) 1.58
Adjuvant immunotherapy with BCG in treatment of regional-lymph-node metastases from malignant melanoma. N Engl J Med (1976) 1.57
Does complete resection of melanoma metastatic to solid intra-abdominal organs improve survival? Ann Surg Oncol (2001) 1.57
Magnetic resonance imaging in juvenile asymmetric segmental spinal muscular atrophy. J Neurol Sci (1997) 1.55
A new American Joint Committee on Cancer staging system for cutaneous melanoma. Cancer (2000) 1.52
Prolongation of survival in metastatic melanoma after active specific immunotherapy with a new polyvalent melanoma vaccine. Ann Surg (1992) 1.50
Sentinel lymph nodes show profound downregulation of antigen-presenting cells of the paracortex: implications for tumor biology and treatment. Mod Pathol (2001) 1.48
Parotid region lymphatic mapping and sentinel lymphadenectomy for cutaneous melanoma. Ann Surg Oncol (1999) 1.47
Is amputation necessary for sarcomas? A seven-year experience with limb salvage. Ann Surg (1980) 1.46
In vivo proton MR spectroscopy evaluation of pyogenic brain abscesses: a report of 194 cases. AJNR Am J Neuroradiol (2009) 1.46
Is adjuvant radiotherapy necessary after positive lymph node dissection in head and neck melanomas? Ann Surg Oncol (2000) 1.43
Current management of malignant melanoma. Ann Surg (1990) 1.43
Hepatic resection of metastatic colorectal carcinoma: a ten-year experience. Arch Surg (1982) 1.43
Serum TA90 antigen-antibody complex as a surrogate marker for the efficacy of a polyvalent allogeneic whole-cell vaccine (CancerVax) in melanoma. Ann Surg Oncol (2001) 1.42
Human liposarcomas: tissue cultures containing foci of transformed cells with viral particles. Science (1969) 1.42
Anti-tyrosinase-related protein-2 immune response in vitiligo patients and melanoma patients receiving active-specific immunotherapy. J Invest Dermatol (1998) 1.41
Philadelphia chromosome in essential thrombocythemia? Am J Hematol (1989) 1.40
Occurrence & nucleotide sequence analysis of hepatitis G virus in patients with acute viral hepatitis & fulminant hepatitis. Indian J Med Res (2007) 1.40
Role of percutaneous fine-needle aspiration biopsy in suspected intrathoracic malignancy. Ann Thorac Surg (1991) 1.40
Retroperitoneal sarcomas: a reappraisal of treatment. J Surg Oncol (1981) 1.40
Fine needle aspiration cytology in a case of Sister Mary Joseph's nodule. Acta Cytol (1992) 1.39
Xanthogranulomatous cholecystitis. Fine needle aspiration cytology in 17 cases. Acta Cytol (1997) 1.39
Molecular markers in blood as surrogate prognostic indicators of melanoma recurrence. Cancer Res (2000) 1.38
Granulomatous hepatitis: a complication of B.C.G. immunotherapy. Lancet (1973) 1.38
Enhancement of complement-dependent cytotoxicity by polyvalent melanoma cell vaccine (CancerVax): correlation with survival. Ann Surg Oncol (1999) 1.38
Will the true sentinel node please stand? Ann Surg Oncol (1999) 1.35
Melanoma-associated antigens as messenger RNA detection markers for melanoma. Cancer Res (1997) 1.35
Pathologic features associated with nonsentinel lymph node metastases in patients with metastatic breast carcinoma in a sentinel lymph node. Cancer (2000) 1.34
Neurofibrosarcoma. Cancer (1980) 1.33
Induction of immunologic refractoriness in adults by meningococcal C polysaccharide vaccination. J Infect Dis (1998) 1.33
Cervical thymic cyst: report of a case and review of the literature. Indian J Pathol Microbiol (2001) 1.32
Biodegradable microspheres as controlled-release tetanus toxoid delivery systems. Vaccine (1994) 1.31
Universal application of intraoperative lymphatic mapping and sentinel lymphadenectomy in solid neoplasms. Cancer J Sci Am (1999) 1.30
Prolonged survival for melanoma patients with elevated IgM antibody to oncofetal antigen. J Natl Cancer Inst (1981) 1.30
Advances in the treatment of sarcomas of the extremity. Current status of limb salvage. Cancer (1984) 1.28
Frequency of the Bcl-2/IgH rearrangement in normal individuals: implications for the monitoring of disease in patients with follicular lymphoma. J Clin Oncol (2001) 1.28
Immunologic studies of human sarcomas: Additional evidence suggesting an associated sarcoma virus. Cancer (1970) 1.27
Correlation of in vivo and in vitro assays of immunocompetence in cancer patients. Cancer Res (1974) 1.27
Clinical aspects of unknown primary melanoma. Ann Surg (1980) 1.27
Lymphatic drainage of skin to a sentinel lymph node in a feline model. Ann Surg (1991) 1.27
Noninvasive 31P NMR probes of free Mg2+, MgATP, and MgADP in intact Ehrlich ascites tumor cells. Proc Natl Acad Sci U S A (1980) 1.27
Increased incidence of second primary melanoma in patients with a previous cutaneous melanoma. Ann Surg Oncol (1999) 1.27
A simple relationship between maximal aerobic power and body weight in Indian adolescent boys. Indian J Med Sci (1986) 1.26
Molecular staging of early colon cancer on the basis of sentinel node analysis: a multicenter phase II trial. J Clin Oncol (2001) 1.26
Demonstration of hepatic steatosis by computerized tomography in patients receiving 5-fluorouracil-based therapy for advanced colorectal cancer. Br J Cancer (1998) 1.26
Validation of drying models and rehydration characteristics of betel (Piper betel L.) leaves. J Food Sci Technol (2010) 1.25
Furazolidone in the treatment of cholera. Lancet (1968) 1.24
Double nuclear magnetic resonance observation of electron exchange between ferri- and ferrocytochrome c. Science (1970) 1.24
Natural antibody in human serum to a neoantigen in human cultured cells grown in fetal bovine serum. J Natl Cancer Inst (1974) 1.23
Neuro-endoscopic management of intraventricular neurocysticercosis (NCC). Acta Neurochir (Wien) (2007) 1.23
The determination of the free magnesium level in the human red blood cell by 31P NMR. J Biol Chem (1978) 1.23
Prognostic significance of occult metastases detected by sentinel lymphadenectomy and reverse transcriptase-polymerase chain reaction in early-stage melanoma patients. J Clin Oncol (1999) 1.22